Term
|
Definition
- certain aa's in the CNS bind post-synaptic receptors and act as inhibitory or excitatory neurotransmitters
- inhib/excitatory response is elicited by altering conductance of 1 or more ion-selective channels
|
|
|
Term
γ-aminobutyric acid (GABA) |
|
Definition
- major inhibitory amino acid
|
|
|
Term
|
Definition
- primary excitatory amino acid
|
|
|
Term
GABAergic neurotransmission |
|
Definition
- what most current drugs modulate
|
|
|
Term
|
Definition
- widely distributed in CNS
- consists of protein subunits with a central ion channel
- have α,β, γ subunits families
- GABAA is targeted by largest # of drugs
|
|
|
Term
|
Definition
- 5 subunits, surround central Cl- ion pore that opens in presence of GABA
- Different receptor subtypes play distinct roles in specific neural circiuts
|
|
|
Term
|
Definition
- expressed at lower levels than GABAA
- mostly in spinal cord
- targeted by only a few agents for spasticity
|
|
|
Term
|
Definition
not yet used as a target of pharmacologic agents |
|
|
Term
drugs that modulate GABA receptors |
|
Definition
- affect arousal and attention, memory formation, anxiety, sleep, and muscle tone
- important mech for treatment of focal or widespread neural hyperactivity in epilepsy
- can act at pre- or post-synaptically
|
|
|
Term
|
Definition
occur when the ligand binds to a different site on the receptor to either inhibit or potentiate response
- i.e. benzodiazepines act as + allosteric modulators by binding noncompetitively to ion channels activated by GABA, enhancing the net effect of GABA on channel conductance
|
|
|
Term
Agents that activate GABAA receptors |
|
Definition
- used for sedation, anxiolysis, hypnosis, neuro-protection following stroke or head trauma, control of epilepsy
- Tiagabine (Gabitril), Benzodiazepines, Barbiturates, Baclofen (GABAB receptor agonist)
|
|
|
Term
|
Definition
decreased activity
moderates excitment
calms recipient |
|
|
Term
|
Definition
- produces drowsiness
- facilitates the onset and maintenance of a state of sleep that resembles natural sleep in its electorencephalographic characteristics
- recipient can be aroused easily from
|
|
|
Term
|
Definition
- can be benzodiazepines or non benzodiazepines
|
|
|
Term
|
Definition
- All have similar pharm profiles, but differ in selectivity therefore variability among clinical usefulness of BZD agents
|
|
|
Term
CNS effects of Benzodiazepines |
|
Definition
- sedation→hypnosis→stupor (as dose ↑)
- do not cause true gen. anesthesia b/c awareness usually persists, and relaxation to allow surgery cannot be achieved
- Used as pre-anesthetic to cause amnesia for events subsequent to admin.(Dose dependent)
- Hypnotic: effect different stages of sleep
|
|
|
Term
Respiratory effects of Benzodiazepines |
|
Definition
cause respiratory depression especially in:
- high doses
- COPD
- if given with other resp. depressants (i.e opioids)
|
|
|
Term
Cardiovascular effects of Benzodiazepines |
|
Definition
- minor in normal patients
- In diazepam inj, cardio and resp depressant effects may be caused in part by the propylene glycol vehicle present
|
|
|
Term
|
Definition
- hepatic (CYP3A4) metabolized
- many of their metabolites are pharm active with long t1/2. (cumulative effects with multiple doses)
|
|
|
Term
Non-Benzodiazepine hypnotics |
|
Definition
- structurally unrelated to BZD, but share similar mech of action
- more selecitve for α1 subunit of GABA receptor (thus more specific for sedation with fewer other BZD adverse effects: anxiolytic, muscle relaxant, amnesic effects)
|
|
|
Term
|
Definition
Partial:
simple partial
Complex partial
Generalized:
Absence (petit mal)
Myoclonic
Tonic-clonic (grand mal)
Febrile
Status epilepticus |
|
|
Term
Anti epileptic drug (AED) classes |
|
Definition
I) mostly enhance Na+ channel-mediated inhibition
II) mostly inhibit Ca2+ channels
III) enhance GABA mediated inhibition
IV) Mixed actions |
|
|
Term
|
Definition
- Broad spectrum (reasonable initial choice)
- Narrow spectrum
|
|
|